Subsequent studies found that PAPP‐A is overexpressed in a variety of tumors, such as breast cancer, ovarian cancer and Ewing sarcoma, and that inhibition of PAPP‐A expression suppresses tumor growth and invasion [6, 7, 8]. Here, PAPPA is linked to ovarian carcinoma.